APRETUDE

Apretude

Apretude

(cabotegravir long-acting for PrEP)

Apretude is an HIV-1 integrase strand transfer inhibitor (INSTI).

Prescribing Information, including boxed warning

Patient Information

Stability Tool

Implementation Resources

Telehealth Delivery of Cabotegravir LA for PrEP

APRETUDE Implementation Guidance for Clinics

Long-Acting Agent Resource Center

WHO PrEP Implementation Tool

Long-Acting Injectable PrEP | NASTAD

Long-Acting Injectable PrEP is Here: Frequently Asked Questions (FAQs) for Implementation | NSTAD

Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), and Other HIV Prevention Strategies: Billing and Coding Guide | NASTAD

HPTN 083 website

HPTN 084 website

How Community Engagement Helped Shape the Eboni Study

Making CAB LA PrEP Implementation Work for You: Findings from the Pillar Study

Implementation Podcast series

Flexible Scheduling

Drop-In Injection Visits Guidance

Prescheduled Appointment Guidance

Designated Injection Days Guidance

How to Discuss Sex Health

How to Discuss Sexual Health Guidance

Related links

Learn more about PrEP

Registrational Trials